Our nation’s health regulators stand at a crossroads. In one direction lies advancement through cutting-edge programs; in the other are practices that no longer reflect our best scientific insight. Health officials want to move forward, but external conditions are holding them back.

President Trump can help our nation’s public health talent take the promising path forward by embracing groundbreaking regulatory reforms. Such audacious action will ensure America’s global leadership and national health.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • There isn’t enough nasty things to write about trump. He s a turd wrestler or bottom feeder that he makes a buck on. Notice the key word trump. With this election it was president not emperor. Notice oval office red, white, and blue. Not gold. He s married to a ho ho ho who s wanting to make millions off being 1 st lady when she s in the same gutter as Donald dick drumph trump.

  • We Stage IV Pt.’s and Caregivers must ensure that the 21st century Cures Act becomes a reality and more. It’s still hard to believe in the ” new ” ” patient oriented ” Dr. Pazdur . Back in 2009 – 2014 , he led the FDA ” flexing of it’s regulatory muscle with Big Pharma ” (WSJ, 2011) , while we Stage IV pt.’s were the ones who paid the price. So we protested . His FDA revoked Avastin for breast cancer instead of just black boxing it , his FDA denied early approval for Kadcyla – that decision alone cost thousands of lives. ( Kadcyla was just named one of the top drugs approved in 2013 – few know it could have been approved in 2010 ) . His FDA tried to ban Iclusig and Lemtrada . Both those decisions were overturned . The present FDA nitpicked and argued within itself over the Duchennes and SMA drugs , eteplirsen and nusinersen . We remain skeptical of all the ” powers that be ” in charge in DC , and in Big Pharma. We see that 3 out of the original 4 compassionate use reforms in the 21st Century act have been cut. Left is the weak reform that companies must post a compassionate use policy , including contact info. Wow ! – at least we dying pt.’s won’ be stuck with just an ” investors ” hotline. We want a lot more change .

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy